Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia

https://doi.org/10.22146/jcoemph.57325

Dionita Rani Karyono(1), Anggi Lukman Wicaksana(2*)

(1) Unit for Collaboration, Alumni, and Community Service, Faculty of Medicine, Public Health, and Nursing, UGM
(2) Department of Medical Surgical Nursing, Faculty of Medicine, Public Health, and Nursing UGM
(*) Corresponding Author

Abstract


Indonesia is currently fighting against a novel coronavirus disease, known as COVID-19. Current information of COVID-19 is crucial for healthcare providers. This study aimed to explore the current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. We obtained data of the confirmed cases of COVID-19, characteristics and comorbidities from the official website of Indonesia COVID-19 Task Force. The data were extracted, explored and discussed to respond to the research aims. Up to June 3rd, 2020, it was reported there were 28,233 confirmed cases of COVID-19 in Indonesia. The current prevalence of COVID-19 case was 0.11‰ and transmission was distributed to all provinces in Indonesia. Almost one-third of the COVID-19 infections were in the age group of 31-45 years (29.3%) but the highest mortality rate occurred in elderly people (17.68%). Overall, males slightly dominated and contributed only 6.84% to the mortality rate. Cough (76.2%), history of fever (50.4%), and current fever (47.1%) were the most common symptoms among the patients with COVID-19. For comorbidities, patients with COVID-19 had higher numbers of hypertension (52.1%), diabetes (33.6%), and other cardiovascular diseases (20.9%). Those three comorbidities led the greater proportion of deaths among other comorbidities. The COVID-19 pandemic is still a new challenge for Indonesia.


Keywords


COVID-19, characteristics, comorbidity, Indonesia, pandemic, prevalence

Full Text:

PDF


References

  1. WHO. Coronavirus Update. 2020. [updates: March 11, 2020 cited June, 17 2020]. Available from: www.who.int
  2. WHO. COVID-19 Situation update for the WHO African Region: External Situation Report 4. 2020;1–7 (internet). [cited: June 18, 2020]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331587/SITREP_COVID-19_WHOAFRO_20200325-eng.pdf
  3. Indonesia's Task Force for COVID-19. Peta Sebaran (internet). [cited: June 3, 2020]. Available from: https://covid19.go.id/petasebaran
  4. Kemenkes RI. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Kemenkes RI. 2020;0–115.
  5. Magista M, Hertanti NS. Buku Saku Desa Tangguh COVID-19. 2020. Universitas Gadjah Mada. Available from: https://tropmed.fk.ugm.ac.id/2020/04/14/buku-saku-desa-tangguh-covid-19-ver-1/
  6. United Nation Geoscheme. COVID-19 Coronavirus Pandemic (internet). [update June 3 2020 cited June 3, 2020] Available from: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdUOA?Si#countries
  7. Survei Komuter Jabodetabek. 2019 [Internet]. [Cited 19 July 2020]. Available from: https://databoks.katadata.co.id/datapublish/2020/01/21/seberapa-padat-penduduk-dki-jakarta-2019.
  8. Tosepu R, Gunawan J, Effendy DS, Ahmad LOAI, Lestari H, Bahar H, et al. Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia. Sci Total Environ. 2020;725.
  9. The Jakarta Post. Covid-19-transmission-rate-soars-surabaya-urged-to-restore-restrictions (internet). [cited June 15, 2020] Available from: https://www.thejakartapost.com/news/2020/06/18/as-covid-19-transmission-rate-soars-surabaya-urged-to-restore-restrictions.html
  10. Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493–7.
  11. Niu S, Tian S, Lou J, Kang X, Zhang L, Lian H, et al. Clinical characteristics of older patients infected with COVID-19: a descriptive study. Arch Gerontol Geriatr. 2020;89:104058.
  12. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol. medRxiv. 2020;2.
  13. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with Coronavirus Disease 2019: retrospective study. BMJ. 2020;368.
  14. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
  15. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.
  16. Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14(3):309–21.
  17. Channappanavar R, Fett C, Mack M, Eyck P, Meyerholz D, Perlman S. Sex-based differences in susceptibility to Severe Acute Respiratory Syndrome Coronavirus infection. J Immunol. 2017;198:4046–53.
  18. Li R, Tian J, Yang F, Lv L, Yu J, Sun G, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary hospital near Wuhan, China. J Clin Virol. 2020;127:18–20.
  19. Lv Z, Cheng S, Le J, Huang J, Feng L, Zhang B, et al. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study. Microbes Infect. 2020;22(4–5):195–9.
  20. Sharma R, Agarwal M, Gupta M, Somendra S, Saxena SK. Clinical characteristics and differential clinical diagnosis of novel Coronavirus Disease 2019 (COVID-19). Coronavirus Diseases 2019. 2020;2019:55–70.
  21. Dhochak N, Singhal T, Kabra SK, Lodha R. Pathophysiology of COVID-19: why children fare better than adults? Indian J Pediatr. 2020;87:537–46.
  22. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1,590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5).
  23. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.
  24. Kulkarni S, Jenner BL, Wilkinson I. COVID-19 and hypertension. JRAAS - J Renin-Angiotensin-Aldosterone Syst. 2020;21(2).
  25. Cancarevic I, Malik BH. SARS-CoV-2 (COVID 19) Infection in hypertensive patients and in patients with cardiac disease. Cureus. 2020;2(6):e8557.
  26. Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020.
  27. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Viro. 2020;127.
  28. Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142.
  29. Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific
    considerations for patients with diabetes during coronavirus diseases pandemic: A scoping
    review. Diabetes Metab Syndr. 2020;14(5):1109-1120.
  30. Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes. Metab. 2020;107:154217.
  31. Grasselli G, Ospedale G, Policlinico M, Pesenti A, Ospedale G, Policlinico M, et al. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. 2020;323(16):1545–6.
  32. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):1–13.



DOI: https://doi.org/10.22146/jcoemph.57325

Article Metrics

Abstract views : 28496 | views : 17848

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Journal of Community Empowerment for Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Journal of Community Empowerment for Health
Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada
Jl. Farmako, Sekip Utara, Yogyakarta 55281, Indonesia
Sekretariat Bersama Jurnal Room, 2nd floor above IKM canteen
📧 jcoemph.fk@ugm.ac.id
Instagram @jcoemph.journal
© 2025 Journal of Community Empowerment for Health